Epilepsy remains one of the most common serious neurological conditions with about one in twenty people developing epilepsy in their lifetime.

Although many have their epilepsy controlled with medication, about one third of people with epilepsy continue to have seizures despite treatment.

This figure has not changed significantly over the last few decades, despite new antiepileptic medication.

Epilepsy Research UK annual grant funding has led to significant benefits for people living with epilepsy.

EXAMPLE RESEARCH SUCCESSES

Neuroimaging research funded by ERUK

Neuroimaging research funded by ERUK has been crucial to understanding the brain areas involved in language, learning and memory in children being considered for epilepsy surgery, and to making that surgery safer.

Click here to find out more about the groundbreaking work from Dr Gabriele Lignani

GENE THERAPIES

A grant made by ERUK ten years ago was the beginning of a project which has now resulted in potential gene therapies for drug-resistant epilepsy.

REDUCING MORTALITY RATE

A research team working on a project on epilepsy-related deaths in Scotland spoke at the Scottish parliament on reducing the mortality rate of people with epilepsy.

ANTIEPILEPTIC MEDICATION

Our research has highlighted potential dangers to children born to women taking AEDs, resulting in the government issuing new prescription guidelines.

CLINICAL TRIALS

Clinical trials of existing drugs for the treatment of memory dysfunction in people with temporal lobe epilepsy are underway thanks to support from ERUK for the underpinning research.

IMMUNOTHERAPY

Immunotherapy has been discovered – thanks to ERUK research – to be an effective treatment for faciobrachial dystonic seizures, a seizure disorder affecting the arms and face.

EPILEPSY SURGERY

As a direct result of ERUK-funded research, methods used for focal epilepsy surgery have improved and are being used in specialist neurology clinics, and may lead to altered practice worldwide.

SUBSEQUENT FUNDING GROWTH

Another way to gauge the effectiveness of the early stage projects we fund is to assess the level of subsequent funding they manage to secure from other organisations to progress their work.

Using Researchfish – the independent research impact assessment platform – we have tracked the success of the research we have funded over the last 5 years. Looking at these figures we can confirm that every £1 invested by Epilepsy Research UK has generated a further £5.16 for epilepsy research (current as of September 2019).

Funding leveraged (002)

At a reception held on May 20th at the Royal Society to launch National Epilepsy Week, we announced grant funding of over £1 million across ten research projects all over the UK.

Read More Here

What an amazing day Team ERUK had at the 2019 London Marathon. Fourteen amazing runners taking on this iconic challenge for Epilepsy Research UK and a fantastic cheering squad

Read More Here

Do something amazing today and make a donation. Your money will go to support the pioneering research projects which help and support people with epilepsy

Read More Here